Papers: 10.3390/ijms19113597

https://doi.org/10.3390/ijms19113597

Development of Biomarkers for Inhibition of SLC6A19 (B0AT1)—A Potential Target to Treat Metabolic Disorders

Cited by: 18
Author(s): Kiran Javed, Qi Cheng, Adam J. Carroll, Thy T. Truong, Stefan Bröer
Published: almost 8 years ago

Software Mentions 1